63
Participants
Start Date
November 30, 2012
Primary Completion Date
June 30, 2017
Study Completion Date
June 30, 2017
Prostate Cancer Imaging
After imaging is completed, subjects will be scheduled for a prostate biopsy performed as part of their clinical care. If the imaging has identified suspicious lesions in the prostate, these regions will be made visible for the Urologist to be targeted for additional biopsies. These additional biopsies will undergo histological evaluation and further metabolomic testing to better understand metabolic differences between various grades of prostate cancer lesions.
University of Michigan Health Systems, Ann Arbor
United States Department of Defense
FED
University of Michigan
OTHER